These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8237996)
41. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741 [TBL] [Abstract][Full Text] [Related]
42. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays. Favaloro EJ Blood Coagul Fibrinolysis; 2011 Oct; 22(7):553-64. PubMed ID: 21885953 [TBL] [Abstract][Full Text] [Related]
43. Type 2N von Willebrand disease: Characterization and diagnostic difficulties. Casonato A; Galletta E; Sarolo L; Daidone V Haemophilia; 2018 Jan; 24(1):134-140. PubMed ID: 29115006 [TBL] [Abstract][Full Text] [Related]
44. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease. Castaman G; Lattuada A; Mannucci PM; Rodeghiero F Br J Haematol; 1995 Jan; 89(1):147-51. PubMed ID: 7833254 [TBL] [Abstract][Full Text] [Related]
45. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3. Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493 [TBL] [Abstract][Full Text] [Related]
46. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates. Lin Y; Yang X; Chevrier MC; Craven S; Barrowcliffe TW; Lemieux R; Ofosu FA Haemophilia; 2004 Sep; 10(5):459-69. PubMed ID: 15357771 [TBL] [Abstract][Full Text] [Related]
47. Studies on the platelet surface-associated von Willebrand factor. Martin SE; Johnson MM; Abel RF Am J Hematol; 1994 May; 46(1):1-8. PubMed ID: 8184872 [TBL] [Abstract][Full Text] [Related]
48. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268 [TBL] [Abstract][Full Text] [Related]
49. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Aihara M; Kimura A; Chiba Y; Yoshida Y Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084 [TBL] [Abstract][Full Text] [Related]
50. Investigation of a case of subtype IIC von Willebrand disease: characterization of the variability of this subtype. Mazurier C; Mannucci PM; Parquet-Gernez A; Goudemand M; Meyer D Am J Hematol; 1986 Jul; 22(3):301-11. PubMed ID: 3087159 [TBL] [Abstract][Full Text] [Related]
51. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices. Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027 [TBL] [Abstract][Full Text] [Related]
52. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences. Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467 [TBL] [Abstract][Full Text] [Related]
53. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease. de Romeuf C; Mazurier C Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782 [TBL] [Abstract][Full Text] [Related]
54. Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause. Mehic D; Hofer S; Jungbauer C; Kaider A; Haslacher H; Eigenbauer E; Rejtő J; Schwartz D; Jilma B; Ay C; Pabinger I; Gebhart J Blood Adv; 2020 Oct; 4(20):5157-5164. PubMed ID: 33095871 [TBL] [Abstract][Full Text] [Related]
55. BLOOD TYPE O IS A RISK FACTOR FOR HYPERFIBRINOLYSIS AND MASSIVE TRANSFUSION AFTER SEVERE INJURY. DeBot M; Eitel AP; Moore EE; Sauaia A; Lutz P; Schaid TR; Hadley JB; Kissau DJ; Cohen MJ; Kelher MR; Silliman CC Shock; 2022 Dec; 58(6):492-497. PubMed ID: 36548640 [TBL] [Abstract][Full Text] [Related]
56. Lung Transplantation for Pulmonary Fibrosis Associated With Hermansky-Pudlak Syndrome. A Single-center Experience. Benvenuto L; Qayum S; Kim H; Robbins H; Shah L; Dimango A; Magda G; Grewal H; Lemaitre P; Stanifer BP; Sonett J; D'Ovidio F; Arcasoy SM Transplant Direct; 2022 Apr; 8(4):e1303. PubMed ID: 35350109 [TBL] [Abstract][Full Text] [Related]
57. Oculocutaneous albinism and bruising in two sisters--probable Hermansky-Pudlak syndrome. Ellis JP; Gray A; Richards F J R Soc Med; 1995 May; 88(5):293P-294P. PubMed ID: 7636828 [TBL] [Abstract][Full Text] [Related]
58. rim2 (recombination-induced mutation 2) is a new allele of pearl and a mouse model of human Hermansky-Pudlak syndrome (HPS): genetic and physical mapping. Sagai T; Koide T; Endo M; Tanoue K; Kikkawa Y; Yonekawa H; Ishiguro S; Tamai M; Matsuda Y; Wakana S; Shiroishi T Mamm Genome; 1998 Jan; 9(1):2-7. PubMed ID: 9434937 [TBL] [Abstract][Full Text] [Related]
59. Hermansky-Pudlak syndrome: report of a case with histological, immunohistochemical and ultrastructural findings. Husain S; Marsh E; Saenz-Santamaria MC; McNutt NS J Cutan Pathol; 1998 Aug; 25(7):380-5. PubMed ID: 9765024 [TBL] [Abstract][Full Text] [Related]
60. Pigment, platelets, and Hermansky-Pudlak in human and mouse. Erickson RP Proc Natl Acad Sci U S A; 1997 Aug; 94(17):8924-5. PubMed ID: 9256409 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]